COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies
The world remains cautiously optimistic about a COVID-19 vaccine that is relatively safe and efficacious and that offers sufficient long-lasting protection/immunity by neutralizing the virus infectivity. However, key technical hurdles pertaining to antigen-adjuvant formulation, delivery, and manufac...
Saved in:
Main Author: | Shyam Rele (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress and future opportunities in the development of vaccines against atherosclerosis
by: Dania O. Govea-Alonso, et al.
Published: (2017) -
The need and challenges for development of vaccines against emerging infectious diseases
by: Sue Ann Costa Clemens, et al.
Published: (2023) -
Challenges and solutions in the development of vaccines against emerging and neglected infectious diseases
by: Joel N. Maslow
Published: (2019) -
Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development
by: Christine C. Roberts
Published: (2019) -
Impact of Refutational Two-Sided Messages on Attitudes Toward Novel Vaccines Against Emerging Infectious Diseases During the COVID-19 Pandemic
by: Hideo Okuno, et al.
Published: (2022)